≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of other and unspecified major salivary glands

Endpoint Browser

C3_SALIVARYNAS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C08
  • Cause of death: ICD-9 — 142
  • Cause of death: ICD-8 — 142
  • Cause of death: excluded ICD-9 — 1420
  • Cancer registry: Topography ICD-O-3 — C08
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

119

4. Check minimum number of events

None

119

5. Include endpoints

None

119

6. Filter based on genotype QC (FinnGen only)

115

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 115 55 60
Unadjusted period prevalence (%) 0.02 0.02 0.03
Median age at first event (years) 65.17 64.74 65.57

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
119
Matched controls
1190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ELB30
NOMESCO Finland
Excision of submandibular gland
894.7
57.7
52
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
35.8
57.3
39
16
XX3DW
NOMESCO Finland
Time consuming IT work
27.7
55.2
42
23
C08.09
ICD-10 Finland
Malignant tumor of the submandibular or submaxillary gland, other or unspecified histology
+∞
44.6
40
*
WZC00
NOMESCO Finland
Treatment plan or consultation
13.0
43.9
84
186
130
Kela drug reimbursment
Malignant tumour
+∞
42.2
38
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
42.2
38
*
D11.70
ICD-10 Finland
Gland sublingual
454.6
34.8
33
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
32.9
28.3
37
16
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
27.1
25
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
26.0
24
*
H02AB02
ATC
dexamethasone; systemic
115.3
25.9
27
*
C08.02
ICD-10 Finland
Cystic adenocarcinoma of the submandibular or submaxillary glands
+∞
24.9
23
*
8200/3-C08.0
ICD-O-3
Adenoid cystic carcinoma of submandibular gland
+∞
21.5
20
*
N02AA05
ATC
oxycodone; systemic
6.9
21.4
43
90
Z51.5
ICD-10 Finland
Palliative care
27.7
20.7
28
13
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
19.3
18
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
19.3
18
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
223.8
19.1
19
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
18.2
17
*
C08.00
ICD-10 Finland
Malignant tumor of submandibular or submaxillary gland, not histology
+∞
18.2
17
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.3
17.9
38
83
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
31.2
17.7
23
9
A04AA02
ATC
granisetron; systemic, transdermal
+∞
17.1
16
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
105.1
17.1
18
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
98.4
16.0
17
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
14.9
14
*
WF002
NOMESCO Finland
Radical radiotherapy
84.8
13.9
15
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
84.8
13.9
15
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
24.8
13.8
19
9
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
29.9
13.8
18
7
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
13.8
13
*
SAA03
NOMESCO Finland
Extended examination of mouth
4.1
13.1
68
293
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.7
12
*
C08.0
ICD-10 Finland
Malignant neoplasm: Submandibular gland
+∞
12.7
12
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
12.7
12
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
12.7
12
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
12.7
12
*
WZC30
NOMESCO Finland
Teaching
5.1
12.0
30
74
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.8
12.0
69
314
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
17.4
11.7
18
12
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
132.3
11.6
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
132.3
11.6
12
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
11.6
11
*
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
11.6
11
*
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
11.6
11
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.0
11.6
46
162
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
22.8
11.5
16
8
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
120.2
10.6
11
*
L03AA13
ATC
pegfilgrastim; parenteral
120.2
10.6
11
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
+∞
10.6
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.6
10
*
C08.01
ICD-10 Finland
Diverse adenocarcinoma of the mandibular salivary gland
+∞
10.6
10
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
10.6
10
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.5
10.2
29
79
JN6AD
NOMESCO Finland
CT of torso and neck
44.1
10.2
12
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
60.0
9.8
11
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
33.0
9.6
12
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
108.3
9.6
10
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
108.3
9.6
10
*
L03AA02
ATC
filgrastim; parenteral
+∞
9.5
9
*
L02BB03
ATC
bicalutamide; oral
+∞
9.5
9
*
A07AA02
ATC
nystatin; oral
7.7
9.2
21
32
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
26.4
9.1
12
5
JN4BD
NOMESCO Finland
Extensive body CT
7.5
8.6
20
31
WX402
NOMESCO Finland
General anaesthesia
3.8
8.6
31
100
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
8.4
8
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
8430/3-C08.0
ICD-O-3
Mucoepidermoid carcinoma of submandibular gland
+∞
8.4
8
*
C08.9
ICD-10 Finland
Malignant neoplasm: Major salivary gland, unspecified
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
36.1
8.2
10
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
27.0
7.7
10
*
EBA10
NOMESCO Finland
Operative extraction of tooth
4.4
7.6
21
55
JN4AD
NOMESCO Finland
Body CT examination
7.1
7.6
18
29
R4190
NOMESCO Finland
Nutritional therapy
14.6
7.6
12
9
C08.91
ICD-10 Finland
Adenocarcinoma of mixed cell type in unspecified large salivary gland
+∞
7.4
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.4
7
*
8200/3-C08.9
ICD-O-3
Adenoid cystic carcinoma of major salivary gland, NOS
+∞
7.4
7
*
A04AD12
ATC
aprepitant; systemic
+∞
7.4
7
*
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
7.4
7
*
XW000
NOMESCO Finland
Bone marrow biopsy
9.7
7.3
14
16
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
32.2
7.3
9
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
42.5
6.8
8
*
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
15.4
6.5
10
7
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
73.6
6.5
7
*
A04AA01
ATC
ondansetron; systemic, rectal
12.0
6.4
11
10
C08.99
ICD-10 Finland
Malignant tumor of unspecified large salivary gland, other or unspecified histology
+∞
6.3
6
*
C08.89
ICD-10 Finland
Malignant overall tumor the large salivary glands anna or unspecified histology
+∞
6.3
6
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
6.3
6
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
EJB30
NOMESCO Finland
Excision of tumor or other lesion of floor of the mouth
+∞
6.3
6
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.5
6.1
16
40

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
44
23
29.77
59.15
1.8
1.2
—
—
—
0
0
49
217
3.14
8.21
4.8
3.7
—
—
—
0
0
57
281
2.97
7.82
3.4
2.0
2.37
2.35
mmol/l
0.83
51
231
71
395
2.98
7.79
6.0
5.9
—
—
—
0
0
24
72
3.92
7.29
1.5
1.1
—
—
—
0
0
54
271
2.82
7.01
2.8
1.5
—
—
—
0
0
74
447
2.73
6.55
5.5
5.6
0.16
0.20
e9/l
1.11
68
386
73
439
2.71
6.50
10.4
3.6
9.55
11.83
umol/l
1.94
68
411
18
59
3.42
4.75
4.5
4.1
1.17
0.96
%
—
6
14
17
54
3.51
4.70
4.7
4.2
0.00
0.13
%
—
5
8
17
55
3.44
4.57
4.7
4.2
0.00
0.10
%
—
5
10
65
420
2.21
4.31
7.2
5.4
1.21
1.22
mmol/l
0.30
46
366
92
687
2.49
4.29
11.5
5.1
80.85
75.98
u/l
0.35
82
630
20
76
2.96
4.15
1.5
1.5
—
—
—
0
0
20
80
2.80
3.78
5.4
2.9
—
—
—
0
0
59
385
2.06
3.64
5.8
4.8
1.20
1.22
mmol/l
1.13
48
343
15
52
3.16
3.61
5.2
4.3
0.80
0.30
%
—
5
10
64
436
2.01
3.45
18.8
13.3
1.20
1.32
inr
0.62
26
136
14
48
3.17
3.43
1.6
1.6
—
—
—
0
0
21
94
2.50
3.19
1.8
1.4
—
—
—
0
0
41
244
2.04
3.17
2.4
2.0
—
—
—
0
0
37
217
2.02
2.95
1.5
1.3
—
—
—
0
0
22
107
2.30
2.79
1.9
1.9
—
—
—
0
0
6
10
6.25
2.73
2.5
4.3
—
—
—
0
0
86
692
1.88
2.42
4.4
4.1
12.64
11.47
mm/h
0.36
76
622
71
551
1.72
2.14
5.5
4.0
6.99
6.81
mmol/l
0.32
66
504
10
39
2.70
1.99
4.0
3.2
—
—
—
0
0
52
384
1.63
1.81
16.4
8.4
0.00
0.00
e9/l
0.50
46
312
105
938
2.01
1.68
21.5
11.8
33.48
21.60
mg/l
2.05
87
697
33
220
1.69
1.68
5.3
3.7
0.00
0.00
estimate
-0.00
15
70
32
214
1.68
1.61
8.6
4.9
—
—
—
0
0
108
984
2.06
1.48
22.7
14.3
139.26
139.80
mmol/l
1.25
103
947
6
22
2.82
1.45
1.0
1.4
5.90
10.23
mg/l
—
6
22
22
137
1.74
1.42
1.6
1.7
—
—
—
0
0
7
29
2.50
1.41
1.6
1.7
17.84
47.19
u/ml
—
7
29
11
54
2.14
1.38
1.9
1.2
—
—
—
0
0
11
54
2.14
1.38
5.2
3.1
—
—
—
0
0
19
118
1.73
1.24
1.9
1.6
—
—
—
0
0
5
20
2.56
1.16
6.0
2.0
3.88
4.65
e9/l
—
5
20
5
20
2.56
1.16
6.0
2.8
57.40
60.15
%
—
5
20
111
1044
1.94
1.13
30.1
17.7
4.43
4.55
e12/l
1.57
106
1002
111
1044
1.94
1.13
29.6
17.7
40.12
40.82
%
0.77
101
975
41
315
1.46
1.10
3.0
3.8
20.43
65.92
e6/l
1.14
31
213
34
253
1.48
1.07
3.4
3.3
—
—
—
0
0
12
68
1.85
1.05
1.9
1.3
66.44
66.62
g/l
0.03
12
59
106
983
1.72
1.02
20.2
11.1
—
—
—
0
0
6
27
2.29
0.95
3.5
3.0
—
0.12
—
0
8
6
29
2.12
0.90
3.0
2.0
—
—
—
0
0
107
1002
1.67
0.89
24.8
14.1
77.91
80.22
umol/l
0.52
107
1002
33
254
1.41
0.87
2.9
2.9
0.22
0.33
e6/l
0.53
28
182
12
73
1.72
0.85
6.0
3.1
—
—
—
0
0
43
348
1.37
0.84
3.6
3.4
—
5.74
—
0
21
0
24
0.00
0.80
0.0
1.2
—
3.18
—
0
17
0
24
0.00
0.80
0.0
1.4
—
288.22
—
0
18
107
1010
1.59
0.75
13.8
8.7
24.59
25.66
u/l
0.36
98
958
21
280
0.70
0.74
1.1
1.7
1.53
1.36
mmol/l
0.48
16
224
7
40
1.80
0.72
22.9
8.7
—
—
—
0
0
10
61
1.70
0.71
5.3
1.6
8.18
10.43
g/l
—
10
55
13
187
0.66
0.68
1.2
1.3
0.37
1.08
u/ml
—
6
51
34
274
1.34
0.67
2.8
3.0
14.24
315.80
e6/l
0.66
27
202
5
28
1.82
0.67
2.0
1.9
—
—
—
0
0
32
257
1.34
0.65
2.9
3.3
7.39
7.40
ph
—
10
35
11
71
1.61
0.64
1.3
1.3
—
—
—
0
0
5
30
1.70
0.62
1.0
1.3
—
—
—
0
0
50
431
1.28
0.60
4.7
3.5
0.00
0.00
estimate
-0.00
15
79
69
623
1.26
0.55
4.8
4.1
—
—
—
0
0
77
707
1.25
0.52
3.9
3.9
14.52
15.03
pmol/l
0.90
66
625
46
399
1.25
0.51
5.1
3.4
78.84
48.23
ng/l
0.33
38
292
30
248
1.28
0.49
3.0
2.7
—
—
—
0
0
10
70
1.47
0.43
9.2
7.3
—
—
—
0
0
74
686
1.21
0.41
4.0
3.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
49
439
1.20
0.39
5.2
4.9
0.00
0.00
estimate
-0.00
16
73
91
953
0.81
0.38
4.2
4.7
1.44
1.45
mmol/l
0.09
78
858
87
914
0.82
0.37
3.7
4.3
1.28
1.29
mmol/l
0.01
75
816
5
76
0.64
0.37
1.6
1.2
—
—
—
0
0
94
980
0.81
0.36
4.6
5.3
2.75
2.69
mmol/l
0.23
81
888
36
316
1.20
0.35
2.9
3.2
2099.54
75.59
mg/l
0.48
21
196
11
83
1.36
0.33
1.2
1.2
—
—
—
0
0
38
337
1.19
0.33
3.8
3.8
6.01
9.38
mg/mmol
0.48
22
203
7
54
1.31
0.31
2.4
1.2
0.73
1.09
g/l
—
7
48
24
206
1.21
0.29
4.3
3.6
—
—
—
0
0
28
318
0.84
0.28
2.5
3.4
—
—
—
0
0
9
74
1.23
0.26
5.2
2.7
—
—
—
0
0
37
334
1.16
0.26
2.8
3.1
7.54
7.44
mmol/l
0.04
30
275
6
81
0.73
0.25
2.5
1.9
437.00
349.52
nmol/l
—
6
73
48
445
1.13
0.23
4.8
3.5
0.00
0.00
estimate
-0.00
16
68
93
959
0.86
0.22
3.9
4.7
4.64
4.57
mmol/l
0.24
78
869
21
239
0.85
0.22
1.6
1.5
21.04
22.04
nmol/l
0.10
15
195
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.33
—
0
5
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
9.94
—
0
6
0
12
0.00
0.21
0.0
1.0
—
1.38
—
0
6
23
203
1.16
0.21
1.7
1.8
572.29
472.16
pmol/l
0.49
17
159
9
113
0.78
0.21
1.7
1.8
—
—
—
0
0
6
48
1.26
0.20
13.7
6.1
25.05
24.99
mmol/l
—
6
48
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
17
148
1.17
0.18
1.2
1.7
29.69
29.76
s
0.01
17
143
38
353
1.11
0.17
2.4
2.6
156.70
126.40
ug/l
0.25
33
322
22
198
1.14
0.16
2.0
1.7
1.92
1.15
mg/l
0.40
16
149
34
364
0.91
0.14
3.5
3.8
1.94
1.81
ug/l
0.15
27
316
13
114
1.16
0.12
1.4
1.4
—
—
—
0
0
26
241
1.10
0.11
4.1
3.1
—
—
—
0
0
89
871
1.09
0.10
4.6
4.7
2.20
1.88
mu/l
1.38
77
776
5
48
1.04
0.09
3.4
4.1
—
—
—
0
0
22
205
1.09
0.08
2.2
2.6
0.63
0.72
ug/l
0.38
15
122
7
64
1.10
0.08
2.4
1.3
—
—
—
0
0
93
915
1.08
0.07
5.8
6.1
40.01
40.40
mmol/mol
0.17
81
841
95
938
1.06
0.05
4.5
4.8
6.14
6.03
mmol/l
0.37
82
842
21
216
0.97
0.00
2.4
2.0
3.14
2.68
mg/l
0.50
16
183
41
408
1.01
0.00
1.9
2.0
97.79
94.98
pmol/l
0.09
16
191
29
289
1.00
0.00
4.7
4.2
—
—
—
0
0
14
142
0.98
0.00
1.4
1.1
—
—
—
0
0
18
185
0.97
0.00
2.0
1.6
1372.49
1284.43
nmol/l
0.10
11
138
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
11.0
—
1065.00
—
0
5
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
2330.00
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
1.02
—
0
7
0
8
0.00
-0.00
0.0
1.6
—
16.64
—
0
8
8
84
0.95
-0.00
1.3
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
10.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.7
—
—
—
0
0
6
60
1.00
-0.00
1.5
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
1.50
—
0
7
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
11.47
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
153.14
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_SALIVARYNAS – Malignant neoplasm of other and unspecified major salivary glands

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).